Effect of swainsonine, an inhibitor of glycoprotein processing, on cultured mammalian cells.
D000268:Adhesiveness; D000470:Alkaloids / Q000494:pharmacology*; D000596:Amino Acids / Q000378:metabolism; D000818:Animals; D050260:Carbohydrate Metabolism; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D003208:Concanavalin A / Q000378:metabolism; D006224:Cricetinae; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004926:Escherichia coli / Q000378:metabolism; D005260:Female; D006023:Glycoproteins / Q000502:physiology*; D007422:Intestines; D007668:Kidney; D037102:Lectins; D008545:Melanoma; D008565:Membrane Proteins / Q000502:physiology*; D051379:Mice; D010053:Ovary; D012276:Ricin / Q000494:pharmacology; D017026:Swainsonine; D014617:Vacuoles / Q000187:drug effects; D014909:Wheat Germ Agglutinins
D000470:Alkaloids; D000596:Amino Acids; D006023:Glycoproteins; D037102:Lectins; D008565:Membrane Proteins; D014909:Wheat Germ Agglutinins; D003208:Concanavalin A; D012276:Ricin; D017026:Swainsonine